BNP for pediatrics - Not quite ready for primetime

Pediatric Critical Care Medicine

Volumn 7, Issue 4, 2006, Pages 388-389

  Oishi, Peter E ^a   Fineman, Jeffrey R ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Atrial natriuretic peptide; B type natriuretic peptide; Cardiopulmonary bypass; Congenital heart disease; Congestive heart failure; Guanosine 3 ,5 monophosphate; Nitric oxide

Indexed keywords

BIOLOGICAL MARKER; BRAIN NATRIURETIC PEPTIDE; NESIRITIDE; STEROID;

ADRENAL FUNCTION; CLINICAL TRIAL; CONGESTIVE HEART FAILURE; CRITICAL ILLNESS; DIAGNOSTIC PROCEDURE; EDITORIAL; FOOD AND DRUG ADMINISTRATION; HEART DISEASE; HOMEOSTASIS; HUMAN; MEDICAL PRACTICE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RISK ASSESSMENT; RISK BENEFIT ANALYSIS; SENSITIVITY AND SPECIFICITY; TREATMENT OUTCOME;

BIOLOGICAL MARKERS; CHILD; CRITICAL CARE; HEART DEFECTS, CONGENITAL; HUMANS; INFANT; NATRIURETIC AGENTS; NATRIURETIC PEPTIDE, BRAIN; PERIOPERATIVE CARE;

EID: 33745930530     PISSN: 15297535     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.PCC.0000225022.27358.92     Document Type: Editorial

References (15)

1. Costello JM, Goodman DM, Green TP: A review of the natriuretic hormone system's diagnostic and therapeutic potential in critically ill children. Pediatr Crit Care Med 2006; 7:308-318
2. Doust JA, Glasziou PP, Pietrzak E, et al: A systematic review of the diagnostic accuracy of natriuretic peptides for heart failure. Arch Intern Med 2004; 164:1978-1984
3. Doust JA, Pietrzak E, Dobson A, et al: How well does B-type natriuretic peptide predict death and cardiac events in patients with heart failure: Systematic review. BMJ 2005, 330:625
4. Troughton RW, Frampton CM, Yandle TG, et al: Treatment of heart failure guided by plasma aminoterminal brain natriuretic peptide (N-BNP) concentrations. Lancet 2000; 355:1126-1130
5. Roy LF, Ogilvie RI, Larochelle P, et al: Cardiac and vascular effects of atrial natriuretic factor and sodium nitroprusside in healthy men. Circulation 1989; 79:383-392
6. Kielstein JT, Impraim B, Simmel S, et al: Cardiovascular effects of systemic nitric oxide synthase inhibition with asymmetrical dimethylarginine in humans. Circulation 2004; 109:172-177
7. McMullan DM, Bekker JM, Parry AJ, et al: Alterations in endogenous nitric oxide production after cardiopulmonary bypass in lambs with normal and increased pulmonary blood flow. Circulation 2000; 102(19 Suppl 3):III172-III178
8. Beghetti M, Silkoff PE, Caramori M, et al: Decreased exhaled nitric oxide may be a marker of cardiopulmonary bypass-induced injury. Ann Thorac Surg 1998;66:532-534
9. Bremer YA, Salloum F, Ockaili R, et al: Sildenafil citrate (viagra) induces cardioprotective effects after ischemia/reperfusion injury in infant rabbits. Pediatr Res 2005; 57:22-27
10. Choi BM, Lee KH, Eun BL, et al: Utility of rapid B-type natriuretic peptide assay for diagnosis of symptomatic patent ductus arteriosus in preterm infants. Pediatrics 2005; 115:e255-e261
11. Puddy VF, Amirmansour C, Williams AF, et al: Plasma brain natriuretic peptide as a predictor of haemodynamically significant patent ductus arteriosus in preterm infants. Clin Sci (Lond) 2002; 103:75-77
12. Reynolds EW, Ellington JG, Vranicar M, et al: Brain-type natriuretic peptide in the diagnosis and management of persistent pulmonary hypertension of the newborn. Pediatrics 2004; 114:1297-1304
13. Hoffman TM, Wernovsky G, Atz AM, et al: Efficacy and safety of milrinone in preventing low cardiac output syndrome in infants and children after corrective surgery for congenital heart disease. Circulation 2003; 107:996-1002
14. Wernovsky G, Wypij D, Jonas RA, et al: Postoperative course and hemodynamic profile after the arterial switch operation in neonates and infants. A comparison of low-flow cardiopulmonary bypass and circulatory arrest. Circulation 1995; 92:2226-2235
15. Shih CY, Sapru A, Oishi P, et al: Alterations in plasma B-type natriuretic peptide levels after repair of congenital heart defects: A potential perioperative marker. J Thorac Cardiovasc Surg 2006; 131:632-638